Pharmaceutical Prime Vendor
Awarded Award Notice Posted
- Solicitation number
- SPM2DP08R0009
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPM2DX-10-D-0027
- NAICS code
- 446110 Pharmacies and Drug Stores
- PSC
- Not on record
- Place of performance
- All Medical Treatment Facilities Oconus-Eurpoean and Pacific, United States
Notice details come from SAM.gov. Updated .
Notice text
5 versions
Update #5 · Latest ·
Added: Mar 17, 2010 2:06 pm
Combined OCONUS (Europe and Pacific) Regions - Secondary Supplier Segment Award:
DMS Pharmaceutical Group, Inc.
Base Period - 20 months
2 Option Periods - 20 months (if exercised)
Update #4 ·
Added: Mar 17, 2010 1:56 pm
Combined OCONUS (Europe and Pacific) Regions - Primary Supplier Segment Award:
Base Period - 20 months
2 Option Periods - 20 months each (if exercised)
Update #3 ·
Added: Jun 30, 2008 2:48 pm Modified: Mar 30, 2009 4:36 pmTrack Changes Item Description: Pharmauectical Items. This acquisition will cover medical pharmaceuticals, including narcotics, in the 6505 Stock catalog/schedule and the current National Drug Code (NDC) database. Soliciation Date March 30, 2009. Closing date April 30, 2009. The purpose of this acquisition is for the Defense Supply Center Philadelphia (DSCP) to cover continuous support for Pharmaceutical Prime Vendor (PPV) for the European and Pacific regions. The European region encompasses all Medical Treatment Facilities (MTFs) located on the Continent of Europe including Turkey plus the surrounding seas and oceans as well as Oman and Bahrain. The Pacific region will encompass all MTFs located in the Pacific including Guam, Diego Garcia and the surrounding seas and oceans. The resultant contracts will be awarded for a twenty month base period and two-twenty month options for a total of five years. The estimated value of the base period is $219,038,406 with a 5-year aggregate total of $657,115,218. Solicitation can be found on the EBS DIBBS web-site - https:/www.dibbs.bsm.dla.mil/
Update #2 ·
Added: Jun 30, 2008 2:48 pm Modified: Dec 03, 2008 9:45 amTrack Changes Item Description: Pharmauectical Items. This acquisition will cover medical pharmaceuticals, including narcotics, in the 6505 Stock catalog/schedule and the current National Drug Code (NDC) database. Soliciation Date March 21, 2009. Closing date April 21, 2009. The purpose of this acquisition is for the Defense Supply Center Philadelphia (DSCP) to cover continuous support for Pharmaceutical Prime Vendor (PPV) for the European and Pacific regions. The European region encompasses all Medical Treatment Facilities (MTFs) located on the Continent of Europe including Turkey plus the surrounding seas and oceans as well as Oman and Bahrain. The Pacific region will encompass all MTFs located in the Pacific including Guam, Diego Garcia and the surrounding seas and oceans. The resultant contracts will be awarded for a twenty month base period and two-twenty month options for a total of five years. The estimated value of the base period is $219,038,406 with a 5-year aggregate total of $657,115,218. Soliciation will not become available until the solicitation issue date. Copy of the solicitation can be found on the EBS DIBBS web-site - https:/www.dibbs.bsm.dla.mil/
Update #1 ·
Added: Jun 30, 2008 2:48 pm This Acquisition covers the re-establishment of Pharmaceutical Prime Vendor Contracts for the new Tricare Military Health System Region. There will be two regions under this solicitation covering the entire OCONUS areas-European and Pacific Region. Both regional contracts will include a base ordering period of 2 years plus 3 two-year option periods for a maximum of 8 years. We will select a primary Pharmaceutical supplier for both regions. If it is in the best interest to the Government, we will select a secondary supplier for the European and Pacific Region. The Pacific Region Procruement has an estimated dollar value of $80,054,178 for the 2 year base ording period and a total estimated dollar value for 8 years of $320,216,712. The European Region Procurement has an estimated dollar value of $281,658,052 for the 2 year base ordering period and a total estimated dollar for 8 years of $1,126,632,208. The combined solicitation value for the total 8 years is $1,446,848,920.
Attachments
| File | Type | Posted |
|---|---|---|
| AMEND 0009 - SPM2DP08R0009.pdf | ||
| AMEND 0008 - SPM2DP08R0009.pdf | ||
| AMEND 0007 - SPM2DP08R0009.pdf | ||
| AMEND 0006 - SPM2DP08R0009.pdf | ||
| FDA Authorization - 11.06.1997.pdf | ||
| AMEND 0005 - SPM2DP08R0009.pdf | ||
| AMEND 0004 - SPM2DP08R0009.pdf | ||
| AMEND 0003 - SPM2DP08R0009.pdf | ||
| AMEND 2 - PPV GEN III OCONUS USAGE.xls | XLS spreadsheet | |
| AMEND 2 - WRM - PACOM PHARM REQMTS.xls | XLS spreadsheet | |
| AMEND 0002 - SPM2DP08R0009.pdf | ||
| AMEND 2 - WRM - EUCOM CENTCOM PHARM REQMTS.xls | XLS spreadsheet | |
| AMEND 0001 - SPM2DP08R0009.pdf | ||
| PPV GEN III OCONUS Solicitation SPM2DP-08-R-0009.pdf |
Show all 14
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity